Rutgers Named Study Site for Monitoring, Predicting Kidney Risk in COVID-19 Patients
October 15, 2020
October 15, 2020
NEW BRUNSWICK, New Jersey, Oct. 15 (TNSRes) -- Rutgers University issued the following news:
Rutgers New Jersey Medical School will be a clinical test site for a study assessing the long term risk of chronic kidney disease in patients who recover from COVID-19.
The Multi-Center Assessment of Survivors for Kidney Disease after COVID-19 (MASKeD-COVID) study - conducted by the Division of Nephrology at Mount Sinai - will assess risk in up to 4,000 patients who have recover . . .
Rutgers New Jersey Medical School will be a clinical test site for a study assessing the long term risk of chronic kidney disease in patients who recover from COVID-19.
The Multi-Center Assessment of Survivors for Kidney Disease after COVID-19 (MASKeD-COVID) study - conducted by the Division of Nephrology at Mount Sinai - will assess risk in up to 4,000 patients who have recover . . .